EUCTR2020-004377-44-AT进行中（未招募）1 期
Ambroxol inhalation for mucus clearance in palliative care patients - a randomized placebo-controlled double-blind pilot study.
Med. Univ. Wien, Innere Med. I, Abt. f. Palliativmedizin0 个研究点目标入组 20 人开始时间: 2021年7月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients over 18 years of age,
- •- No pregnancy
- •- History of more than three sputum sputum sputum sputum sputum sputum sputum sputum sputum sputum sputum per day,
- •- No mucolytic medication
- •- No reasons for non-participation (e.g., cognitive deficit, delirium, marked dementia or severe psychiatric illness, excessively poor performance status, severe septicemia with impaired consciousness, intolerance of ABX)
- •- No language barrier
- •- Given ability to sign verbal as well as written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
ebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO)gram-negative bacillus pneumonia acquired during mechanical ventilation in patients receiving Extracorporeal Membrane veno-arterial oxygenationMedDRA version: 20.1Level: LLTClassification code: 10035701Term: Pneumonia gram-negative bacterial NOS Class: 10021881MedDRA version: 20.0Level: SOCClassification code: 10021881Term: Infections and infestations Class: 1CTIS2023-509722-22-00Assistance Publique Hopitaux De Paris26
尚未招募
不适用
Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID casesCTRI/2020/10/028581Dr Tushar Patel
招募中
不适用
Albuterol for Acute Lung InjuryACTRN12613000836730south valley university50
招募中
不适用
se of surfactant with corticosteroids to prevent chronic lung disease in premature infantsBronchopulmonary dysplasia originating in the perinatal periodP27.1RBR-72kkgcHospital das Clínicas da Universidade Federal de Goiás
进行中（未招募）
不适用
Whole lung lavage followed by inhaled Sargramostim in the treatment of autoimmune pulmonary alveolar proteinosis. - WLL/inhaled GM-CSF in autoimmune PAPEUCTR2008-007086-23-ITOSPEDALE POLICLINICO S. MATTEO